- Home
- SFM vs LEGN Comparison
SFM vs LEGN Comparison
Compare SFM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFM | LEGN |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.9B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SFM | LEGN |
|---|---|---|
| Price | $80.53 | $25.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $98.89 | $61.33 |
| AVG Volume (30 Days) | 2.0M | ★ 2.3M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.60 | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $8,806,159,000.00 | N/A |
| Revenue This Year | $8.95 | $42.68 |
| Revenue Next Year | $7.36 | $30.52 |
| P/E Ratio | $47.62 | ★ N/A |
| Revenue Growth | ★ 14.08 | N/A |
| 52 Week Low | $64.75 | $16.24 |
| 52 Week High | $182.00 | $45.30 |
Technical Indicators
Market Signals| Indicator | SFM | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.96 | 70.05 |
| Support Level | $76.09 | $25.71 |
| Resistance Level | $86.46 | $26.72 |
| Average True Range (ATR) | 3.23 | 1.62 |
| MACD | 0.87 | 0.15 |
| Stochastic Oscillator | 76.16 | 87.67 |
Price Performance
Historical ComparisonAbout SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.